SkinTERM have developed a policy brief to provide an overview of the SkinTERM project outputs to inform policy and decision makers on the advances made in the field of regenerative skin therapies and urge the European Commission and national health authorities to accelerate clinical adoption, integrate findings into treatment guidelines, and support reimbursement pathways.